Fig. 1From: Quantitative site- and structure-specific N-glycoproteomics characterization of differential N-glycosylation in MCF-7/ADR cancer stem cellsIntact N-glycopeptides identified (FDR ≤ 1%; a) and differentially expressed N-glycopeptides quantified (two out of three technical replicates, ≥ 1.5 fold, p < 0.05; b) from C18-RPLC-MS/MS (HCD) analysis of the 1:1 mixture of isotopically diethylated intact N-glycopeptides from MCF7/ADR and MCF7/ADR CSCsBack to article page